Ovarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-
based chemotherapy is poor in some patients and, thus, current research is focusing on new …

Ovarian cancer is the leading cause of death in women with gynecological cancer. Most
patients are diagnosed at an advanced stage and have a poor prognosis. Currently, surgical …

Ovarian cancer is the leading cause of death in women with gynecological cancer. Most
patients are diagnosed at an advanced stage with a poor prognosis. Currently, surgical …

Ovarian cancer is the most lethal gynecologic malignancy. It appears that the vast majority of
what seem to be primary epithelial ovarian and primary peritoneal carcinomas is, in fact …

Background/Aim: We aimed to identify the most effectual groups of targeted therapies for
ovarian cancer in recent clinical trials. Materials and Methods: A systematic literature review …

Ovarian cancer is one of the most common causes of death in women as survival is highly
dependent on the stage of the disease. Ovarian cancer is typically diagnosed in the late …

Epithelial ovarian cancer (EOC) remains a clinical challenge and there is a need to optimise
the currently available treatment and to urgently develop new therapeutic strategies …

Ovarian cancer is the most lethal gynecological cancer, mainly because of the delay in
diagnosis. Recently, much effort has been put into investigating and introducing novel …

Ovarian cancer accounts for approximately 4% of cancer deaths in women worldwide, with
around 225,000 estimated new cases diagnosed each year and 140,000 related deaths …

An improved understanding of the genomics of ovarian cancer and the separation of ovarian
cancer into histologically and molecularly defined subgroups have affected drug …